Bristol-Myers Squibb Co to Discuss ESMO Highlights Call
שיחת ועידה Bristol-Myers Squibb Co
Bristol-Myers Squibb Co Conference call will be held on 28/09/2019. During the earnings conference call's session Bristol-Myers Squibb Co will provide updated information and financial status.
Conference call is also referred to as: teleconference call or audio conference bridge. Conferencing service is provided in house or as cloud based teleconference service.
In order to join the audio conferencing dial conference bridge and key in the PIN code, Contact Bristol-Myers Squibb Co for this information
Schedule an online conference with QCONF conference service and get 5 free calls with online conferencing.
Bristol-Myers Squibb Company (which may be referred to as Bristol-Myers Squibb, BMS, the Company, we, our or us) was incorporated under the laws of the State of Delaware in August 1933 under the name Bristol-Myers Company, as successor to a New York business started in 1887. In 1989, Bristol-Myers Company changed its name to Bristol-Myers Squibb Company as a result of a merger. We are engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of biopharmaceutical products on a global basis. We operate in one segment--BioPharmaceuticals. For additional information about business segments, refer to "Item 8. Financial Statements--Note 2. Business Segment Information." We compete with other worldwide research-based drug companies, smaller research companies and generic drug manufacturers. Our products are sold worldwide, primarily to wholesalers, retail pharmacies, hospitals, government entities and the medical profession.קרא עוד שיחת ועידה